ClinicalThought


Share

Program Content

Activities

  • CD38 and BCMA as Targets in Myeloma
    Key Insights on CD38 and BCMA as Targets for Therapy in Multiple Myeloma
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 28, 2024

    Expires: August 27, 2025

Faculty

cover img faculity

Thomas G. Martin, MD

Clinical Professor of Medicine
Associate Chief, Division of Hematology/Oncology
Co-Lead, Cancer Immunology and Immunotherapy Program
Helen Diller Family Comprehensive Cancer Center
University of California, San Francisco
San Francisco, California

cover img faculity

Craig Emmitt Cole, MD

Associate Professor of Medicine
Department of Oncology
Karmanos Cancer Institute
Wayne State University School of Medicine
Detroit, Michigan

cover img faculity

Noopur Raje, MD

Professor of Medicine
Harvard Medical School
Director, Center for Multiple Myeloma
Massachusetts General Hospital
Boston, Massachusetts

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from Sanofi.

Sanofi